Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 11, 2011
[Strategy for patients with low-risk coronary artery disease: initial medical therapy only or PCI plus medical therapy]Kazuhiko NishigakiCirculation Journal : Official Journal of the Japanese Circulation Society|June 12, 2020
Safety and Efficacy of Human Muse Cell-Based Product for Acute Myocardial Infarction in a First-in-Human TrialToshiyuki Noda, Kazuhiko Nishigaki, Shinya MinatoguchiCirculation Journal : Official Journal of the Japanese Circulation Society|December 26, 2003
Sarpogrelate, a 5-HT2 receptor blocker, may have a preconditioning-like effect in patients with coronary artery diseaseEishun Horibe, Kazuhiko Nishigaki, Shinya Minatoguchi, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|June 1, 2004
Assessment of acute myocardial infarction in Japan by the Japanese Coronary Intervention Study (JCIS) GroupKazuhiko Nishigaki, Tsutomu Yamazaki, Masanori Fukunishi, et al.Neurosurgery|August 4, 2010
Demonstration of intraluminal thrombus in the carotid artery by optical coherence tomography: technical case reportShinichi Yoshimura, Masanori Kawasaki, Arihiro Hattori, et al.Journal of Electrocardiology|November 12, 2017
Microvolt T-wave alternans monitoring in a patient with levofloxacin-induced Torsade de PointesYuki Sahashi, Nobuhiro Takasugi, Genki Naruse, et al.Internal Medicine (Tokyo, Japan)|September 3, 2013
Cerebral microembolism following coronary angiography--a prospective comparative study between left cardiac catheterization and multidetector computed tomography-Yasunori Ohi, Yoshihiro Uno, Toshiki Oohira, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|March 28, 2006
Outcomes of patients with stable low-risk coronary artery disease receiving medical- and PCI-preceding therapies in Japan: J-SAP study 1-1Shintaro Tanihata, Kazuhiko Nishigaki, Masanori Kawasaki, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 7, 2006
Long-term and strict blood pressure lowering by imidapril reverses left ventricular hypertrophy in patients with essential hypertension: an evaluation using a novel indicator of burden on the left ventricleMasahiko Takahashi, Shinya Minatoguchi, Kazuhiko Nishigaki, et al.International Journal of Cardiology|June 7, 2015
Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal functionTakahide Nawa, Kazuhiko Nishigaki, Yujiro Kinomura, et al.Pageof 10